ºù«Ӱҵ

All publications

Journal articles

• Huang M, Romdhani H, Xie J, Song Y, Lee S, Liu D, Elbasha E, Mohanty S, Rowen D & Kelly MS (2025) . Open Forum Infectious Diseases, 12(Supplement_1).
• Mukuria C, Rowen D, Mulhern B, McDool E, Kharroubi S, Bjorner JB & Brazier JE (2024) . Applied Health Economics and Health Policy, 1-15.
• Carlton J, Powell P, Rowen D, Williams C, Griffiths AW, Hobson E & McDermott C (2024) . Health Qual Life Outcomes, 22(1), 69.
• Powell PA, Rowen D, Keetharuth A, Mukuria C & Shah K (2024) . Soc Sci Med, 355, 117127.
• (2024) . Diabetic Medicine, 41(8).
• Carlton J, Powell PA, Broadley M, de Galan BE, Heller S, Comins J, Rosilio M, Pouwer F, Gall M-A, Child CJ , McCrimmon RJ et al (2024) . Diabetologia, 67(8), 1536-1551.
• Shields A, Chen SC, Kaur MN, Rowen D, Layton A, Thiboutot D, Tan J & Barbieri JS (2024) . J Am Acad Dermatol, 91(1), 144-146.
• Mukuria C, Rowen D, Acaster S, McGarry LJ, Lou Y, Sosnay PR & Quittner AL (2024) . J Patient Rep Outcomes, 8(1), 24.
• Matza LS, Stewart KD, Fournier M, Rowen D, Lachmann R, Scarpa M, Mengel E, Obermeyer T, Ayik E, Laredo F & Pulikottil-Jacob R (2024) . Eur J Health Econ, 25(8), 1437-1448.
• Rowen D, Carlton J, Terheyden JH, Finger RP, Wickramasekera N, Brazier J & MACUSTAR Consortium (2024) . Value Health, 27(5), 642-654.
• Kharroubi SA, Mukuria C, Dawoud D & Rowen D (2024) . Value Health Reg Issues, 42, 100977.
• Wickramasekera N, Hole AR, Rowen D, Wailoo A & Keetharuth AD (2024) . Patient, 17(3), 301-317.
• Bailey C, Howell M, Raghunandan R, Dalziel K, Howard K, Mulhern B, Petrou S, Rowen D, Salisbury A, Viney R , Lancsar E et al (2024) . Pharmacoeconomics, 42(4), 435-446.
• Aragón MJ, Gravelle H, Castelli A, Goddard M, Gutacker N, Mason A, Rowen D, Mannion R & Jacobs R (2024) . Soc Sci Med, 344, 116582.
• Powell PA, Rowen D, Keetharuth A & Mukuria C (2024) . Soc Sci Med, 340, 116506.
• King MT, Revicki DA, Norman R, Müller F, Viney RC, Pickard AS, Cella D, Shaw JW & MAUCa Consortium (2024) . Pharmacoecon Open, 8(1), 49-63.
• Matza LS, Howell TA, Chun B, Hetherington L, White M, Weiss T, Huang M, Rowen D, Tan T, Feemster K , Nozad B et al (2023) . Value in Health, 26(12), S478-S479.
• Rowen D, Mukuria C, Cooper S, Bray N, Carlton J, Longworth L, Meads D, Oluboyede Y, O'Neill C & Yang Y (2023) . Value in Health, 26(12), S361-S361.
• von der Emde L, Mallwitz M, Vaisband M, Hasenauer J, Saßmannshausen M, Terheyden JH, Agostini H, Altay L, Atia R, Bandello F , Basile PG et al (2023) . Scientific Reports, 13(1).
• Rowen D, Mukuria C, Bray N, Carlton J, Cooper S, Longworth L, Meads D, O'Neill C & Yang Y (2023) . Value Health, 26(11), 1625-1635.
• Devlin NJ, Pan T, Sculpher M, Jit M, Stolk E, Rowen D, van Hout B & Norman R (2023) . Pharmacoeconomics, 41(10), 1165-1174.
• Wang H, Rowen DL, Brazier JE & Jiang L (2023) . Appl Health Econ Health Policy, 21(3), 405-418.
• Peasgood T, Bourke M, Devlin N, Rowen D, Yang Y & Dalziel K (2023) . Soc Sci Med, 323, 115818.
• Mukuria C, Peasgood T, McDool E, Norman R, Rowen D & Brazier J (2023) . Value Health, 26(7), 1073-1084.
• Kularatna S, Chen G, Norman R, Mukuria C, Rowen D, Senanayake S, Hettiarachchi R, Mulhern B, Fozzard K, Parsonage W & MacPhail SM (2023) . Qual Life Res, 32(4), 1151-1163.
• Acaster S, Mukuria C, Rowen D, Brazier JE, Wainwright CE, Quon BS, Duckers J, Quittner AL, Lou Y, Sosnay PR & McGarry LJ (2023) . Value Health, 26(4), 567-578.
• Carlton J, Powell P, Rowen D, Broadley M, Pouwer F, Speight J, Heller S, Gall M-A, Rosilio M, Child CJ , Comins J et al (2023) . Diabet Med, 40(3), e15007.
• Powell PA, Karimi M, Rowen D, Devlin N, van Hout B & Brazier JE (2023) . Qual Life Res, 32(4), 1187-1197.
• Garzone D, Terheyden JH, Morelle O, Wintergerst MWM, Saßmannshausen M, Schmitz-Valckenberg S, Pfau M, Thiele S, Poor S, Leal S , Holz FG et al (2022) . Scientific Reports, 12.
• Hussain H, Keetharuth A, Rowen D & Wailoo A (2022) . Health Qual Life Outcomes, 20(1), 152.
• Keetharuth AD, Hussain H, Rowen D & Wailoo A (2022) . Health Qual Life Outcomes, 20(1), 139.
• Rowen D, Mukuria C, Bray N, Carlton J, Longworth L, Meads D, O'Neill C, Shah K & Yang Y (2022) . Soc Sci Med, 309, 115227.
• Rowen D, Mukuria C & McDool E (2022) . Pharmacoeconomics, 40(9), 863-882.
• Bansback N, Trenaman L, Mulhern BJ, Norman R, Metcalfe R, Sawatzky R, Brazier JE, Rowen D & Whitehurst DGT (2022) . CMAJ Open, 10(3), E589-E598.
• Powell PA & Rowen D (2022) . Patient, 15(6), 669-678.
• Peasgood T, Mukuria C, Rowen D, Tsuchiya A & Wailoo A (2022) Should we consider including a value for ‘hope’ as an additional benefit within HTA?. Value in Health, 25(9), 1619-1623.
• Peasgood T, Mukuria C, Rowen D, Tsuchiya A & Wailoo A (2022) . Value in Health, 25(9), 1619-1623.
• Rowen D, Wickramasekera N, Hole AR, Keetharuth A & Wailoo A (2022) . Value Health, 25(8), 1404-1415.
• Ramos-Goñi JM, Estévez-Carrillo A, Rivero-Arias O, Rowen D, Mott D, Shah K & Oppe M (2022) . Value Health, 25(7), 1196-1204.
• Rowen D, Mukuria C, Powell PA & Wailoo A (2022) . Pharmacoeconomics, 40(5), 479-488.
• Rowen D, Powell PA, Hole AR, Aragon M-J, Castelli A & Jacobs R (2022) . Soc Sci Med, 301, 114885.
• Brazier J, Peasgood T, Mukuria C, Marten O, Kreimeier S, Luo N, Mulhern B, Pickard AS, Augustovski F, Greiner W , Engel L et al (2022) . Value Health, 25(4), 482-491.
• Rogers HJ, Sagabiel J, Marshman Z, Rodd HD & Rowen D (2022) . Health Qual Life Outcomes, 20(1), 18.
• Powell PA, Carlton J, Rowen D, Brazier J, Facey K, Bayley K, Chandler F, Godfrey J & Crossley E (2022) . Med Decis Making, 42(2), 139-140.
• Kaur MN, Skolasky RL, Powell PA, Xie F, Huang I-C, Kuspinar A, O'Dwyer JL, Cizik AM & Rowen D (2022) . Qual Life Res, 31(4), 1191-1198.
• Kularatna S, Rowen D, Mukuria C, McPhail S, Chen G, Mulhern B, Whitty JA, Byrnes J, Scuffham P, Atherton J , Höfer S et al (2022) . Qual Life Res, 31(1), 257-268.
• Powell PA, Rowen D, Rivero-Arias O, Tsuchiya A & Brazier JE (2021) . Health Qual Life Outcomes, 19(1), 222.
• Matza LS, Stewart KD, Lloyd AJ, Rowen D & Brazier JE (2021) . Value Health, 24(6), 812-821.
• Powell PA, Carlton J, Rowen D, Chandler F, Guglieri M & Brazier JE (2021) . Neurology, 96(19), e2438-e2450.
• King MT, Norman R, Mercieca-Bebber R, Costa DSJ, McTaggart-Cowan H, Peacock S, Janda M, Müller F, Viney R, Pickard AS , Cella D et al (2021) . Value Health, 24(6), 862-873.
• Rowen D, Powell P, Mukuria C, Carlton J, Norman R & Brazier J (2021) . Value Health, 24(10), 1499-1510.
• Peasgood T, Mukuria C, Carlton J, Connell J, Devlin N, Jones K, Lovett R, Naidoo B, Rand S, Rejon-Parrilla JC , Rowen D et al (2021) . Eur J Health Econ, 22(7), 1067-1081.
• Terheyden JH, Behning C, Lüning A, Wintergerst L, Basile PG, Tavares D, Melício BA, Leal S, Weissgerber G, Luhmann UFO , Crabb DP et al (2021) . BMC Medical Research Methodology, 21.
• Rogers HJ, Marshman Z, Rodd H & Rowen D (2021) . J Patient Rep Outcomes, 5(1), 26.
• Rowen D, Keetharuth AD, Poku E, Wong R, Pennington B & Wailoo A (2021) . Value Health, 24(3), 443-460.
• Keetharuth AD, Rowen D, Bjorner JB & Brazier J (2021) . Value Health, 24(2), 281-290.
• Rogers HJ, Gilchrist F, Marshman Z, Rodd HD & Rowen D (2020) . J Patient Rep Outcomes, 4(1), 105.
• Comans TA, Nguyen K-H, Ratcliffe J, Rowen D & Mulhern B (2020) . Pharmacoeconomics, 38(8), 871-881.
• Terheyden JH, Holz FG, Schmitz-Valckenberg S, Lüning A, Schmid M, Rubin GS, Dunbar H, Tufail A, Crabb DP, Binns A , Sánchez CI et al (2020) . Trials, 21(1).
• Hill H, Rowen D, Pennington B, Wong R & Wailoo A (2020) . Value Health, 23(7), 907-917.
• Mulhern BJ, Bansback N, Norman R & Brazier J (2020) . Medical Care, 58(6), 566-573.
• Brazier JE, Mulhern BJ, Bjorner JB, Gandek B, Rowen D, Alonso J, Vilagut G, Ware JE & SF-6Dv2 International Project Group (2020) . Med Care, 58(6), 557-565.
• Rowen D, Rivero-Arias O, Devlin N & Ratcliffe J (2020) . Pharmacoeconomics, 38(4), 325-340.
• Carlton J, Rowen D & Elliott J (2020) . Health Qual Life Outcomes, 18(1), 59.
• Kharroubi SA, Beyh Y, Harake MDE, Dawoud D, Rowen D & Brazier J (2020) . Int J Environ Res Public Health, 17(3).
• Norman R, Mercieca-Bebber R, Rowen D, Brazier JE, Cella D, Pickard AS, Street DJ, Viney R, Revicki D, King MT & European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group and the MAUCa Consortium (2019) . Health Econ, 28(12), 1385-1401.
• Rowen D, Carlton J & Elliott J (2019) . Value Health, 22(8), 845-850.
• Rankin J, Rowen D, Howe A, Cleland JGF & Whitty JA (2019) . Heart Fail Rev, 24(4), 549-563.
• Mukuria C, Rowen D, Harnan S, Rawdin A, Wong R, Ara R & Brazier J (2019) . Appl Health Econ Health Policy, 17(3), 295-313.
• Terheyden JH, Finger RP, Schmitz-Valckenberg S, Agostini H, Dahlke C, Kuehlewein L, Lang GE, Pauleikhoff D, Wolf A, Boettger MK , Luhmann UFO et al (2019) . Der Ophthalmologe, 116(12), 1186-1193.
• Powell PA, Carlton J, Rowen D & Brazier JE (2019) . BMJ Open, 9(3), e023685.
• Kharroubi SA & Rowen D (2019) . Eur J Health Econ, 20(2), 245-255.
• Brazier JE, Rowen D, Lloyd A & Karimi M (2019) . Value Health, 22(1), 62-68.
• Finger RP, Schmitz-Valckenberg S, Schmid M, Rubin GS, Dunbar H, Tufail A, Crabb DP, Binns A, Sánchez CI, Margaron P , Normand G et al (2019) . Ophthalmologica, 241(2), 61-72.
• Rowen D, Mulhern B, Stevens K & Vermaire JH (2018) . Value Health, 21(10), 1234-1242.
• Rowen D, Labeit A, Stevens K, Elliott J, Mulhern B, Carlton J, Basarir H & Brazier J (2018) . Med Decis Making, 38(6), 699-707.
• Comans TA, Nguyen K-H, Mulhern B, Corlis M, Li L, Welch A, Kurrle SE, Rowen D, Moyle W, Kularatna S & Ratcliffe J (2018) . BMJ Open, 8(1), e018996.
• Rowen D, Stevens K, Labeit A, Elliott J, Mulhern B, Carlton J, Basarir H, Ratcliffe J & Brazier J (2018) . Value Health, 21(1), 69-77.
• King MT, Viney R, Simon Pickard A, Rowen D, Aaronson NK, Brazier JE, Cella D, Costa DSJ, Fayers PM, Kemmler G , McTaggart-Cowen H et al (2018) . Pharmacoeconomics, 36(2), 225-238.
• Brazier J, Rowen D, Karimi M, Peasgood T, Tsuchiya A & Ratcliffe J (2018) . Eur J Health Econ, 19(6), 881-891.
• Stevens K, Brazier J & Rowen D (2018) . Eur J Health Econ, 19(5), 653-661.
• Ara R, Peasgood T, Mukuria C, Chevrou-Severac H, Rowen D, Azzabi-Zouraq I, Paisley S, Young T, van Hout B & Brazier J (2017) . Pharmacoeconomics, 35(Suppl 1), 7-9.
• Ara R, Rowen D & Mukuria C (2017) . Pharmacoeconomics, 35(Suppl 1), 57-66.
• Rowen D, Brazier J, Ara R & Azzabi Zouraq I (2017) . Pharmacoeconomics, 35(Suppl 1), 33-41.
• Brazier J, Ara R, Rowen D & Chevrou-Severac H (2017) . Pharmacoeconomics, 35(Suppl 1), 21-31.
• Rowen D, Azzabi Zouraq I, Chevrou-Severac H & van Hout B (2017) . Pharmacoeconomics, 35(Suppl 1), 11-19.
• Mulhern B, Labeit A, Rowen D, Knowles E, Meadows K, Elliott J & Brazier J (2017) . Diabet Med, 34(9), 1264-1275.
• Carlton J, Elliott J, Rowen D, Stevens K, Basarir H, Meadows K & Brazier J (2017) . Health Qual Life Outcomes, 15(1), 146.
• Mulhern B, Pink J, Rowen D, Borghs S, Butt T, Hughes D, Marson A & Brazier J (2017) . Value Health, 20(4), 687-693.
• Mukuria C, Rowen D, Hernández-Alava M, Dixon S & Ara R (2017) . Appl Health Econ Health Policy, 15(5), 597-614.
• Lorgelly PK, Doble B, Rowen D, Brazier J & Cancer 2015 investigators (2017) . Qual Life Res, 26(5), 1163-1176.
• Rowen D, Dixon S, Hernández-Alava M & Mukuria C (2016) . Eur J Health Econ, 17(6), 733-744.
• King MT, Costa DSJ, Aaronson NK, Brazier JE, Cella DF, Fayers PM, Grimison P, Janda M, Kemmler G, Norman R , Pickard AS et al (2016) . Qual Life Res, 25(3), 625-636.
• Rowen D, Brazier J, Mukuria C, Keetharuth A, Risa Hole A, Tsuchiya A, Whyte S & Shackley P (2016) . Med Decis Making, 36(2), 210-222.
• Rowen D, Brazier J, Keetharuth A, Tsuchiya A & Mukuria C (2016) . Appl Health Econ Health Policy, 14(1), 89-104.
• Norman R, Viney R, Aaronson NK, Brazier JE, Cella D, Costa DSJ, Fayers PM, Kemmler G, Peacock S, Pickard AS , Rowen D et al (2016) . Qual Life Res, 25(3), 637-649.
• Young TA, Mukuria C, Rowen D, Brazier JE & Longworth L (2015) . Medical Decision Making, 35(7), 912-926.
• Mukuria C, Rowen D, Brazier JE, Young TA & Nafees B (2015) . Value Health, 18(6), 846-855.
• Rowen D, Brazier J & Van Hout B (2015) . Med Decis Making, 35(3), 328-340.
• Arnold DT, Rowen D, Versteegh MM, Morley A, Hooper CE & Maskell NA (2015) . Health Qual Life Outcomes, 13, 6.
• Yang Y, Rowen D, Brazier J, Tsuchiya A, Young T & Longworth L (2015) . Value Health, 18(1), 52-60.
• Rowen D, Mulhern B, Banerjee S, Tait R, Watchurst C, Smith SC, Young TA, Knapp M & Brazier JE (2015) . Med Decis Making, 35(1), 68-80.
• Hatswell AJ, Pennington B, Pericleous L, Rowen D, Lebmeier M & Lee D (2014) . Health and Quality of Life Outcomes, 12(1).
• Costa DS, Aaronson NK, Fayers PM, Grimison PS, Janda M, Pallant JF, Rowen D, Velikova G, Viney R, Young TA & King MT (2014) . Patient Relat Outcome Meas, 5, 119-129.
• Chen G, Stevens K, Rowen D & Ratcliffe J (2014) . Health Qual Life Outcomes, 12, 134.
• Mulhern B, Bansback N, Brazier J, Buckingham K, Cairns J, Devlin N, Dolan P, Hole AR, Kavetsos G, Longworth L , Rowen D et al (2014) . Health Technol Assess, 18(12), vii-191.
• Longworth L, Yang Y, Young T, Mulhern B, Hernández Alava M, Mukuria C, Rowen D, Tosh J, Tsuchiya A, Evans P , Devianee Keetharuth A et al (2014) . Health Technol Assess, 18(9), 1-224.
• Mulhern B, Rowen D, Snape D, Jacoby A, Marson T, Hughes D, Baker G & Brazier J (2014) . Epilepsy Behav, 36, 12-17.
• Ferreira LN, Ferreira PL, Pereira LN, Rowen D & Brazier JE (2013) . Value Health, 16(6), 1023-1031.
• Alava MH, Brazier J, Rowen D & Tsuchiya A (2013) . Med Decis Making, 33(6), 839-852.
• Wong CKH, Lam CLK, Wan YF & Rowen D (2013) . Value Health, 16(2), 373-384.
• Mulhern B, Rowen D, Brazier J, Smith S, Romeo R, Tait R, Watchurst C, Chua K-C, Loftus V, Young T , Lamping D et al (2013) . Health Technol Assess, 17(5), v-140.
• Mulhern B, Longworth L, Brazier J, Rowen D, Bansback N, Devlin N & Tsuchiya A (2013) . Value Health, 16(1), 104-113.
• Longworth L & Rowen D (2013) . Value Health, 16(1), 202-210.
• Mavranezouli I, Brazier JE, Rowen D & Barkham M (2013) . Med Decis Making, 33(3), 381-395.
• Rowen D, Young T, Brazier J & Gaugris S (2012) . Value Health, 15(8), 1059-1068.
• Mulhern B, Brazier JE, Rowen D, Young TA, Smith SC & Banerjee S (2012) . Value Health, 15(5), 787-788.
• Brazier JE, Rowen D, Mavranezouli I, Tsuchiya A, Young T, Yang Y, Barkham M & Ibbotson R (2012) . Health Technol Assess, 16(32), 1-114.
• Wong CKH, Lam CLK, Rowen D, McGhee SM, Ma K-P, Law W-L, Poon JTC, Chan P, Kwong DLW & Tsang J (2012) . Value Health, 15(3), 495-503.
• Mulhern B, Rowen D, Jacoby A, Marson T, Snape D, Hughes D, Latimer N, Baker GA & Brazier JE (2012) . Epilepsy Behav, 24(1), 36-43.
• Mulhern B, Smith SC, Rowen D, Brazier JE, Knapp M, Lamping DL, Loftus V, Young TA, Howard RJ & Banerjee S (2012) . Value in Health, 15(2), 323-333.
• Rowen D, Mulhern B, Banerjee S, Hout BV, Young TA, Knapp M, Smith SC, Lamping DL & Brazier JE (2012) . Value Health, 15(2), 346-356.
• Kerr C, Lloyd A, Rowen D, Maslen T & Brazier J (2012) . Health Outcomes Research in Medicine, 3(3).
• Brazier J, Rowen D, Yang Y & Tsuchiya A (2012) . Eur J Health Econ, 13(5), 575-587.
• Rowen D, Brazier J, Tsuchiya A, Young T & Ibbotson R (2012) . Med Decis Making, 32(1), 31-40.
• Ferreira LN, Ferreira PL, Pereira LN & Rowen D (2012) . Applied Research in Quality of Life, 7(2), 193-208.
• Rowen D, Brazier J, Tsuchiya A & Alava MH (2012) . Health Economics, 21(6), 715-729.
• Rowen D, Brazier J, Young T, Gaugris S, Craig BM, King MT & Velikova G (2011) . Value Health, 14(5), 721-731.
• Cruz LN, Camey SA, Hoffmann JF, Rowen D, Brazier JE, Fleck MP & Polanczyk CA (2011) . Value in Health, 14(5 SUPPL.).
• Brazier J, Rowen D, Tsuchiya A, Yang Y & Young TA (2011) . Soc Sci Med, 73(2), 245-253.
• Ferreira LN, Ferreira PL, Rowen D & Brazier JE (2011) . Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 20(4), 609-619.
• Versteegh MM, Rowen D, Brazier JE & Stolk EA (2010) . Health Qual Life Outcomes, 8, 141.
• Lloyd A, Kerr C, Rowen D, Maslen T & Brazier J (2010) . Value in Health, 13(7), A380-A381.
• Young TA, Rowen D, Norquist J & Brazier JE (2010) . Qual Life Res, 19(6), 907-917.
• Ferreira LN, Ferreira PL, Pereira LN, Brazier J & Rowen D (2010) . VALUE HEALTH, 13(5), 624-630.
• Brazier JE, Yang Y, Tsuchiya A & Rowen DL (2010) . Eur J Health Econ, 11(2), 215-225.
• Rowen D, Brazier J & Roberts J (2009) . Health Qual Life Outcomes, 7, 27.
• Dietrich M & Rowen D (2005) . Journal of Interdisciplinary Economics, 16(3), 247-269.
• Terheyden JH, Dunbar HMP, Schmitz-Valckenberg S, Behning C, Martinho C, Luhmann UFO, Saßmannshausen M, Lüning A, Miliu A, Aires ID , Basile PG et al () . Eye.
• Shiroiwa T, Yamamoto Y, Murata T, Mulhern B, Bjorner J, Brazier J, Fukuda T, Rowen D & Fukuhara S-I () . Quality of Life Research.
• Matza L, Howell TA, Chun B, Hetherington L, White M, Weiss T, Huang M, Rowen D, Tan T, Feemster K , Nozad B et al () Health State Utilities Associated with Invasive Pneumococcal Disease, Pneumonia, and Recurrent Acute Otitis Media in Young Children. Quality of Life Research.
• Rowen D, McDool E, Carlton J, Powell P & Norman R () Deriving a Preference-Weighted Measure for People with Hypoglycaemia from the Hypo-RESOLVE-QoL. Value in Health.
• Wickramasekera N, Shackley P & Rowen D () . Journal of Medical Internet Research.
• Garzone D, Terheyden JH, Morelle O, Wintergerst MWM, Saßmannshausen M, Schmitz-Valckenberg S, Pfau M, Thiele S, Poor S, Leal S , Holz FG et al () . Scientific Reports, 13(1).
• Dunbar HMP, Behning C, Abdirahman A, Higgins BE, Binns AM, Terheyden JH, Zakaria N, Poor S, Finger RP, Leal S , Holz FG et al () . JAMA Ophthalmology.
• Terheyden JH, Pondorfer SG, Behning C, Berger M, Carlton J, Rowen D, Bouchet C, Poor S, Luhmann UFO, Leal S , Holz FG et al () Disease-specific assessment of Vision Impairment in Low Luminance (VILL) in age-related macular degeneration – a MACUSTAR study report. British Journal of Ophthalmology.

Chapters

• Rowen D (2023) , Encyclopedia of Quality of Life and Well-Being Research (pp. 5432-5433). Springer International Publishing
• Rowen D (2023) , Encyclopedia of Quality of Life and Well-Being Research (pp. 5429-5432). Springer International Publishing
• Rowen D (2022) Preference-Weighted Health States In Maggino F (Ed.), Encyclopedia of Quality of Life and Well-Being Research
• Rowen D (2021) , Encyclopedia of Quality of Life and Well-Being Research (pp. 1-3). Springer International Publishing
• Rowen D (2014) , Encyclopedia of Quality of Life and Well-Being Research (pp. 5028-5030). Springer Netherlands
• Rowen D (2014) , Encyclopedia of Quality of Life and Well-Being Research (pp. 5026-5028). Springer Netherlands
• Rowen D & Brazier J (2014) , Encyclopedia of Health Economics (pp. 358-365). Elsevier
• Brazier J, Roberts J & Rowen D (2012) Methods for developing preference-based measures of health, The Elgar Companion to Health Economics: Second Edition (pp. 395-405).
• Rowen D & Brazier J (2011) (pp. 787-813). Oxford University Press

Conference proceedings papers

• Rowen D, Carlton J, McDool E, Terheyden JH & Finger RP (2024) . Value in Health, Vol. 27(12) (pp S132-S132)
• Terheyden JH, Behning C, Rowen DL, Carlton J, Dunbar HMP, Zakaria N, Leal S, Luhmann UFO, Schmid M, Crabb DP , Holz FG et al (2024) Vision Impairment in Low Luminance Reports and Progression of Intermediate Age-Related Macular Degeneration in the MACUSTAR Study Cohort. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Vol. 65(7)
• Powell P, Astrom M, Burstrom K, Berg J, Carlton J, Henriksson M, Norman R, Rowen D & Shah K (2024) Who Should Value Health-Related Quality of Life in Children? Results from a Dual Country Survey. QUALITY OF LIFE RESEARCH, Vol. 33 (pp S45-S45)
• Terheyden JH, Behning C, Rowen D, Carlton J, Crabb DP, Dunbar HMP, Zakaria N, Luhmann UFO, Leal S, Schmid M , Holz FG et al (2024) Patient-relevance of visual function decline in intermediate age-related macular degeneration a MACUSTAR study report. QUALITY OF LIFE RESEARCH, Vol. 33 (pp S75-S75)
• Rowen D, McDool E, Carlton J, Powell P, Norman R, de Galan B, Gall M-A, McCrimmon R, Rosilio M & Heller S (2024) Eliciting preferences of people living with diabetes using the Hypo-RESOLVE-QoL-8D to determine the impact of hypoglycaemia to inform economic evaluation. QUALITY OF LIFE RESEARCH, Vol. 33 (pp S95-S95)
• Rowen D, Carlton J, McDool E, Terheyden JH, Poor S, Zakaria N & Finger RP (2024) Assessing the psychometric performance of a new condition-specific preference-weighted measure, VILL-UI, and EQ-5D-5L in patients with age-related macular degeneration: A MACUSTAR Study Report. QUALITY OF LIFE RESEARCH, Vol. 33 (pp S213-S213)
• Rowen D, Carlton J, Mcdool E, Terheyden JH & Finger RP (2024) PSYCHOMETRIC PERFORMANCE OF EQ-5D-5L AND VILLUI, A NEW CONDITION-SPECIFIC PREFERENCE-WEIGHTED MEASURE, IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION: A MACUSTAR STUDY REPORT. VALUE IN HEALTH, Vol. 27(12)
• Hussain H, Keetharuth A, Rowen D & Wailoo A (2023) Convergent validity of EQ-5D with core outcomes in dementia: a systematic review. QUALITY OF LIFE RESEARCH, Vol. 32(SUPPL 1) (pp S10-S10)
• Carlton J, Powell P, Rowen D, Broadley M, Pouwer F, Speight J, Heller S, Gall M-A, Rosilio M, Child CJ , Comins J et al (2023) The Hypo-RESOLVE QoL: a new patient reported outcome (PRO) to quantify the impact of hypoglycaemia on health-related quality of life. DIABETOLOGIA, Vol. 66(SUPPL 1) (pp S427-S427)
• Rowen D, Mukuria C, Cooper S, Bray N, Carlton J, Longworth L, Meads D, Oluboyede Y, O'Neill C & Yang Y (2023) UNDERTAKING STUDIES TO INFORM PUBLIC POLICY: MANAGING DATA COLLECTION TO ENSURE DATA QUALITY IN THE EQ-5D-5L UK VALUATION THROUGH THE USE OF INDEPENDENT QUALITY CONTROL ASSESSMENTS. VALUE IN HEALTH, Vol. 26(12) (pp S361-S361)
• Sutherland CS, Davies E, Sully K, Patel A, Marti-Gil Y, Lloyd A, Rowen D, Stewart K, Matza LS, PA P & Daigl M (2023) SELECTING PREFERENCE-BASED MEASURES (PBMS) FOR PEDIATRIC STUDIES: A PROPOSED DECISION MAKING FRAMEWORK. VALUE IN HEALTH, Vol. 26(12) (pp S475-S475)
• Schurer M, Jones E, Powell P, Rowen D, Baker S, Warner A, Muraro A, Girard F & Makwana N (2023) Health state utilities in children with peanut allergy and their parents: A UK vignette study. ALLERGY, Vol. 78
• Matza LS, Howell TA, Chun B, Hetherington L, White M, Weiss T, Huang M, Rowen D, Tan T, Feemster K , Nozad B et al (2023) ASSESSMENT OF HEALTH STATE UTILITIES FOR INVASIVE PNEUMOCOCCAL DISEASE, PNEUMONIA, AND ACUTE OTITIS MEDIA IN YOUNG CHILDREN. VALUE IN HEALTH, Vol. 26(12) (pp S478-S479)
• Carlton J, Powell P, Rowen D, Brazier J, Broadley M, Pouwer F, Child C, Rosilio M, McCrimmon R, Gall M-A , De Galan B et al (2022) . Quality of Life Research, Vol. 31(Suppl 2) (pp S91-S91). Prague, Czech Republic, 19 October 2022 - 19 October 2022.
• Kharroubi S, El Harakeh M, Dawoud D, Rowen D & Brazier JE (2022) . Value in Health, Vol. 25(7) (pp S574-S574)
• Kharroubi S, El Harakeh M, Dawoud D, Rowen D & Brazier JE (2022) VALUATION OF SF-6D HEALTH STATES: IS IT FEASIBLE AND ACCEPTABLE IN A LEBANESE POPULATION. VALUE IN HEALTH, Vol. 25(7) (pp S574-S574)
• Powell P, Rowen D, Mukuria C, Keetharuth A & Wailoo A (2022) Valuing health-related quality of life in children and adolescents: Who should we ask and how? A study protocol for consulting the public and experts in health valuation. QUALITY OF LIFE RESEARCH, Vol. 31 (pp S146-S146)
• Mukuria C, Peasgood T, McDool E, Norman R, Rowen D & Brazier JE (2022) VALUATION OF THE EQ HEALTH AND WELL-BEING SHORT USING TIME TRADE-OFF AND DISCRETE CHOICE EXPERIMENTS: A FEASIBILITY STUDY. VALUE IN HEALTH, Vol. 25(12) (pp S413-S413)
• Carlton J, Powell P, Blome C, Newi A-L, Rowen D, Brazier J, Broadley M, Pouwer F, Child C, Rosilio M , McCrimmon R et al (2022) Exploring the face and content validity of a new patient-reported outcome measure of the impact of hypoglycaemia on quality of life: Results of the Hypo-RESOLVE QoL cognitive interview study. QUALITY OF LIFE RESEARCH, Vol. 31 (pp S59-S59)
• Bailey C, Howell M, Raghunandan R, Dalziel K, Howard K, Mulhern B, Petrou S, Rowen D, Salisbury A, Viney R , Lancsar E et al (2022) DEVELOPMENT OF A CHECKLIST FOR STUDIES REPORTING THE ELICITATION OF STATED PREFERENCES VALUES FOR CHILD HEALTH RELATED QUALITY OF LIFE. VALUE IN HEALTH, Vol. 25(12) (pp S363-S363)
• Rowen D, Brazier J, Carlton J, Terheyden JH, Wickramasekera N & Finger RP (2022) Deriving a preference based measure for age-related macular degeneration from the VILL-33: A MACUSTAR Study Report. QUALITY OF LIFE RESEARCH, Vol. 31 (pp S76-S76)
• White A, Wong R, Guest S, Carroll C, Essat M, Rowen D, Young VJ & Brazier JE (2022) COMPARING NON-ONCOLOGICAL RARE CONDITION SUBMISSIONS TO THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) VERSUS SCOTTISH MEDICINES CONSORTIUM (SMC) FROM 2001 TO 2021. VALUE IN HEALTH, Vol. 25(12) (pp S326-S327)
• White A, Wong R, Guest S, Carroll C, Essat M, Rowen D, Young VJ & Brazier JE (2022) ANALYSIS OF NEUROLOGICAL CONDITIONS SUBMISSIONS TO THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) AND THE SCOTTISH MEDICINES CONSORTIUM (SMC) FROM 2001 TO 2021. VALUE IN HEALTH, Vol. 25(12) (pp S314-S314)
• Rowen D, Mukuria C, Cooper SJ, Bray N, Carlton J, Longworth L, Meads D, O'Neill C, Shah K & Yang Y (2022) ACCESSIBILITY AND INCLUSIVITY FOR PEOPLE PARTICIPATING IN HEALTH PREFERENCE RESEARCH: HOW DOES THE MODE OF ADMINISTERING AN INTERVIEW IMPACT ON TIME TRADE-OFF STUDIES?. VALUE IN HEALTH, Vol. 25(12) (pp S322-S323)
• Terheyden JH, Pondorfer SG, Behning C, Berger M, Rowen D, Carlton J, Holz FG, Butt T, Brazier JE & Finger RP (2021) Psychometric properties of the Vision Impairment in Low Luminance (VILL) questionnaire in age-related macular degeneration in the MACUSTAR study. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Vol. 62(8)
• Bansback N, Mulhern B, Norman R, Trenaman L, Metcalfe R, Sawatzky R, Brazier J, Rowen D & Whitehurst DGT (2020) DEVELOPMENT OF A PREFERENCE BASED SINGLE INDEX FOR THE VR-12 IN CANADA. MEDICAL DECISION MAKING, Vol. 40(1) (pp E53-E54)
• Keetharuth A, Brazier JE, Rowen D & Bjorner J (2019) . Value in Health, Vol. 22 (pp S685-S686)
• Acaster S, Mukuria C, Rowen D, Brazier J, Wainwright C, Quon B, Duckers J, Quittner AL, Lou Y, Sosnay P & McGarry L (2019) DEVELOPMENT OF THE CYSTIC FIBROSIS QUESTIONNAIRE-REVISED PREFERENCE BASED SCORING ALGORITHM. PEDIATRIC PULMONOLOGY, Vol. 54 (pp S443-S443)
• Norman R, Mercieca-Bebber R, Rowen D, Brazier J, Cella D, Pickard AS, Street DJ, Viney R, Revicki D & King M (2019) UK utility weights for the cancer-specific EORTC QLU-C10D: Why, how and when to use?. QUALITY OF LIFE RESEARCH, Vol. 28 (pp S11-S12)
• Hill H, Rowen D, Pennington B, Wong R & Wailoo A (2019) Are child and adolescent-specific measures used to inform resource allocation decisions? A review of the methods used to generate utility values in NICE technology appraisals for children and adolescents. QUALITY OF LIFE RESEARCH, Vol. 28 (pp S110-S110)
• Keetharuth A, Bjorner JB, Rowen D & Brazier J (2019) Using item response theory to construct a health classification system and select health states for valuation for the Preference-Based Index from the Recovering Quality of Life (ReQoL) outcome measure. QUALITY OF LIFE RESEARCH, Vol. 28 (pp S68-S68)
• Rankin J, Rowen D, Howe A, Cleland JG & Whitty JA (2018) . Value in Health, Vol. 21 (pp S388-S389)
• Carlton J, Rowen D & Elliott J (2018) The new health and self-management in diabetes (HASMID-10) measure: assessing psychometric performance in a large longitudinal survey. QUALITY OF LIFE RESEARCH, Vol. 27 (pp S39-S39)
• Rowen D (2018) Use of preferences to inform healthcare resource allocation. QUALITY OF LIFE RESEARCH, Vol. 27 (pp S14-S14)
• King MT, Norman R, Kemmler G, McTaggart-Cowan H, Rowen D, Pickard AS & Viney R (2018) . Value in Health, Vol. 21 (pp S2-S3)
• Velikova G, Valderas JM, Potter C, Batchelder L, A’Court C, Baker M, Bostock J, Coulter A, Fitzpatrick R, Forder J , Fox D et al (2017) . Health and Quality of Life Outcomes, Vol. 15(S1)
• Carlton J, Rowen D & Elliott J (2017) The importance of validation and refinement in PROM development: using the HASMID questionnaire, a measure of self-management in diabetes. QUALITY OF LIFE RESEARCH, Vol. 26(1) (pp 124-124)
• King MT, Norman R, Mercieca-Bebber R, Rowen D, Bonnet P, Cella D, Pickard AS, Brazier JE, Viney R & Revicki DA (2017) Development of United Kingdom value set for EORTC QLU-C10D: multi-attribute utility classification for the EORTC-QLQ-C30. QUALITY OF LIFE RESEARCH, Vol. 26(1) (pp 50-50)
• Elliott J, Carlton J, Rowen D & Brazier J (2017) Changing HbA(1c) units: a hindarance, not a help to patients. DIABETOLOGIA, Vol. 60 (pp S342-S342)
• King MT, Norman R, Viney R, Costa D, Brazier J, Cella D, Gamper E, Kemmler G, McTaggart-Cowan H, Peacock S , Pickard AS et al (2016) . Value in Health, Vol. 19(7) (pp A807-A807)
• Croudace T, Brazier J, Gutacker N, Street A, Robotham D, Waterman S, Rose D, Satkunanathan S, Wykes T, Nasr N , Enderby P et al (2016) . Health and Quality of Life Outcomes, Vol. 14(Suppl 1), 9 June 2016 - 9 June 2016.
• Carlton J, Rowen D, Elliott J, Brazier J, Stevens K, Basarir H & Labeit A (2016) Developing a PROM to evaluate self-management in diabetes (HASMID): giving patients a voice. HEALTH AND QUALITY OF LIFE OUTCOMES, Vol. 14
• Rowen D, Labeit A, Brazier JE, Stevens K, Elliott J, Mulhern B, Carlton J, Basarir H & Meadows K (2016) Valuing the impact of self-management on quality of life in diabetes using discrete choice experiments. QUALITY OF LIFE RESEARCH, Vol. 25 (pp 134-134)
• Costa D, King M, Aaronson N, Brazier J, Cella D, Grimison P, Janda M, McTaggart-Cowan H, Pickard S, Rowen D & Di Sipio T (2014) DO CANCER PATIENTS DISTINGUISH BETWEEN THE IMPORTANCE AND SEVERITY OF THEIR QUALITY OF LIFE CONCERNS?. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 10 (pp 31-31)
• Costa DSJ, King MT, Aaronson NK, Brazier JE, Cella D, Fayers PM, Grimison P, Janda M, McTaggart-Cowan H, Norman R , Pallant J et al (2014) THE DEVELOPMENT OF CANCER-SPECIFIC MULTI-ATTRIBUTE UTILITY INSTRUMENTS FROM THE EORTC QLQ-C30 AND FACT-G. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 10 (pp 31-31)
• Costa DSJ, King MT, Aaronson NK, Brazier JE, Cella D, Grimison P, Janda M, McTaggart-Cowan H, Pickard AS, Arbuckle R , Rowen D et al (2014) Do cancer patients distinguish between the importance and severity of their quality of life concerns?. QUALITY OF LIFE RESEARCH, Vol. 23 (pp 122-122)
• Rowen D, Brazier JE, Keetharuth A, Tsuchiya A, Robinson A & Mukuria C (2014) Comparison of an online survey and face-to-face interviews for eliciting societal preferences. QUALITY OF LIFE RESEARCH, Vol. 23 (pp 49-49)
• Batty A, Winn B, Lebmeier M, Rowen D & Lee D (2012) . VALUE IN HEALTH, Vol. 15(7) (pp A285-A285)
• King MT, Costa DSJ, Aaronson NK, Brazier JE, Cella D, Fayers PM, Pallant JF, Peacock S, Pickard S, Rowen D , Velikova G et al (2012) THE DEVELOPMENT OF AN INTERNATIONALLY-VALID CANCER-SPECIFIC MULTI-ATTRIBUTE UTILITY INSTRUMENT (MAUI) FROM THE EORTC CORE HEALTH-RELATED QUALITY OF LIFE (HRQOL) QUESTIONNAIRE, QLQ-C30. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 8 (pp 335-335)
• Young TA, Rowen D, Mukuria C, Brazier JE & Jr LL (2012) Appropriate mapping functions in HRQL: a series of models mapping from FACT-G to EQ-5D. QUALITY OF LIFE RESEARCH, Vol. 21 (pp 11-11)
• Jr LL, Yang Y, Brazier JE, Rowen D, Tsuchiya A & Young TA (2012) Valuing a vision 'bolt-on' item for the EQ-5D. QUALITY OF LIFE RESEARCH, Vol. 21 (pp 53-54)
• Wong CKH, Lam CLK, Rowen D & Wan EYF (2012) Predicting SF-6D preference-based score based on the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire in colorectal cancer. QUALITY OF LIFE RESEARCH, Vol. 21 (pp 84-84)
• Mulhern B, Tsuchiya A, Brazier JE & Rowen D (2012) How do respondents perceive health state valuation tasks? A 'think aloud' study investigating time trade off and discrete choice experiments. QUALITY OF LIFE RESEARCH, Vol. 21 (pp 53-53)
• Batty A, Winn B, Pericleous L, Rowen D, Lee D & Nikoglou T (2012) A COMPARISON OF GENERAL POPULATION AND PATIENT UTILITY VALUES FOR ADVANCED MELANOMA. ANNALS OF ONCOLOGY, Vol. 23 (pp 372-372)
• King M, Costa DSJ, Aaronson NK, Brazier J, Cella DF, Fayers P, Pallant JF, Peacock S, Pickard AS, Rowen D , Velikova G et al (2012) . VALUE IN HEALTH, Vol. 15(4) (pp A225-A225)
• Young TA, Brazier JE, Rowen D, Tsuchiya A & Yang Y (2012) The impact of adding a generic dimension to a condition-specific preference-based measure. QUALITY OF LIFE RESEARCH, Vol. 20 (pp 10-10)
• Wong CKH, Lam CLK, Ma KP, McGhee SM, Law WL, Poon JTC, Chan P, Kwong DLW, Tsang J, Rowen DL & Brazier JE (2012) Mapping the Functional Assessment of Cancer Therapy-General or -Colorectal to Preference-based Values Measured by SF-6D in Patients with Colorectal Neoplasm. QUALITY OF LIFE RESEARCH, Vol. 20 (pp 26-26)
• Costa DSJ, King MT, Aaronson NK, Brazier JE, Cella DF, Fayers PM, Pallant JS, Peacock S, Pickard S, Rowen D , Velikova G et al (2012) Adaptation of a method for developing a preference-based measure from a descriptive health-related quality of life measure (HRQOL): a confirmatory versus exploratory approach for the cancer-specific QLQ-C30. QUALITY OF LIFE RESEARCH, Vol. 20 (pp 31-31)
• Rowen D, Brazier JE, Tsuchiya A, Young T & Ibbotson R (2012) The impact of condition labelling on health state utility values. QUALITY OF LIFE RESEARCH, Vol. 20 (pp 11-11)
• Batty AJ, Fisher D, Winn B, Wang Q, Tolley K & Rowen D (2011) . VALUE IN HEALTH, Vol. 14(7) (pp A461-A462)
• Brazier J, Rowen D, Tsuchiya A, Young T & Ibbotson R (2011) . VALUE IN HEALTH, Vol. 14(7) (pp A457-A457)
• Meadows K, Mulhern B, Rowen D & Brazier J (2011) . VALUE IN HEALTH, Vol. 14(7) (pp A242-A242)
• Cruz LN, Camey SA, Hoffmann JF, Brazier J, Rowen D, Fleck MP & Polanczyk CA (2010) ESTIMATING THE SF-6D VALUE SET FOR A POPULATION BASED SAMPLE OF BRAZILIANS. VALUE HEALTH, Vol. 13(7) (pp A240-A240)
• Smith SC, Mulhern B, Brazier JE, Lamping DL, Knapp M, Rowen D, Loftus V & Banerjee S (2010) What do people with dementia and their proxies say about HRQL? A quantitative test of qualitative findings. QUALITY OF LIFE RESEARCH, Vol. 19 (pp 14-14)
• Rowen D, Mulhern B, Brazier J, Jacoby A, Marson T, Latimer N, Snape D, Baker G & Hughes D (2010) Using the Liverpool Quality of Life battery to develop a health state classification system for Epilepsy. QUALITY OF LIFE RESEARCH, Vol. 19 (pp 57-57)
• Mulhern BJ, Smith S, Brazier J, Rowen D, Lamping D, Knapp M, Loftus V & Banerjee S (2010) Developing a health state classification system for dementia using Rasch analysis. QUALITY OF LIFE RESEARCH, Vol. 19 (pp 35-36)

Reports

• Bailey C, Howell M, Raghunandan, R, Dalziel K, Howard K, Mulhern B, Petrou S, Rowan D, Salisbury A, Viney R , Lancsar E et al (2023) The RETRIEVE checklist for studies reporting the elicitation of stated preferences for child health related quality of life
• Keetharuth A, Wong R, Hill J, Rowen D & Wailoo A (2023) Health related quality of life in economic evaluations in dementia: state of play and reflections
• Hill H, Rowen D, Keetharuth A, Wailoo A & Hill J (2022) A literature review of methods to measure and value benefits in cost-effectiveness analyses of interventions for patients with either a short life expectancy or receiving palliative care’
• Rowen D, Mukuria C, Powell P, Wong R & Wailoo A (2021) Valuing child health: Exploring the use of a mixed sample of adolescents and adults to value child and adolescent health states
• Keetharuth D & Rowen D (2020) Mapping the Health of Nation Outcomes Scale (HoNOS) onto the Recovering Quality of Life Utility Index (ReQoL-UI)
• Rogers HJ, Gilchrist F, Marshman Z, Rodd HD & Rowen D (2020) Selection and validation of a classification system for a child-centred caries-specific utility measure
• Keetharuth D, Rowen D, Bjorner JB & Brazier J (2020) Estimating a Preference-Based Index for mental health from the Recovering Quality of Life (ReQoL) measure: Valuation of ReQoL-UI
• Rowen D, Brazier J, Wong R & Wailoo A (2020) Measuring and valuing health-related quality of life when sufficient EQ-5D data is not available
• Rowen D, Keetharuth D, Poku E, Wailoo A, Wong R, Pennington R & Brazier J (2019) A review of the psychometric performance of paediatric preference-based measures used to generate utility values for children
• Hill JH, Rowen D, Pennington R, Wailoo A & Wong R (2019) A review of the methods used to generate utility values in NICE technology appraisals for paediatrics
• Mukuria C, Rowen D, Peasgood T & Brazier JE (2016) An empirical comparison of well-being measures used in the UK
• peasgood T, Brazier JE, mukuria C & Rowen D (2014) A conceptual comparison of well-being measures used in the UK.
• Brazier J & Rowen D (2011) NICE DSU Technical Support Document 11: Alternatives to EQ-5D for generating health state utility values
• Longworth L & Rowen D (2011) NICE DSU Technical Support Document 10: The use of mapping methods to estimate health state utility values

Scholarly editions

• Mulhern B, Rowen D, Brazier J, Jacoby A, Marson T, Snape D, Hughes D, Latimer N & Baker GA (2010) Developing a health state classification system from NEWQOL for epilepsy using classical psychometric techniques and Rasch analysis: a technical report.
• Brazier J, Rowen D, Yang Y & Tsuchiya A (2009) Using rank and discrete choice data to estimate health state utility values on the QALY scale.
• Rowen D, Brazier J, Tsuchiya A, Hernández M & Ibbotson R (2009) The simultaneous valuation of states from multiple instruments using ranking and VAS data: methods and preliminary results.
• Rowen D & Dietrich M Incorporating Ethics into Economics: Problems and Possibilities.
• Rowen D & Dietrich M Attitudes and motivations of Economics students: Some recent evidence..
• Rowen D & Dietrich M Are people ethical? An experimental approach.

Posters

• Mukuria C, Peasgood T, Brazier J, Rowen D & Norman R (2020) E-QALY: valuing the items for a new generic preference-based measure using time trade-off and discrete choice experiments.
• Brazier J, Rowen D, Tsuchiya A, Young T & Ibbotson R The impact of conditions labels on health state values.
• Keetharuth A, Rowen D, Bjorner J & Brazier J Estimating a Preference-Based Index from the Recovering Quality of Life measure for economic evaluation in the area of mental health: Valuation of ReQoL-UI.
• Mukuria C, Dixon S, Rowen D & Hernandez M Examining productivity losses associated with health related quality of life using patient data (2014).
• Rowen D, Mulhern B, Vermaire JH & Stevens K Estimating a Dutch value set for the paediatric preference-based CHU-9D using a discrete choice experiment with duration.

Datasets

• Powell P, Carlton J, Rowen D & Brazier J .
• Powell P, Carlton J, Rowen D & Brazier J .

Other

• Norman R, Viney R, Aaronson NK, Brazier JE, Cella D, Costa DSJ, Fayers PM, Kemmler G, Peacock S, Pickard AS , Rowen D et al (2017) . Quality of Life Research.
• King MT, Costa DSJ, Aaronson NK, Brazier JE, Cella DF, Fayers PM, Grimison P, Janda M, Kemmler G, Norman R , Pickard AS et al (2016) . Quality of Life Research, 25(10), 2683-2683.
• Norman R, Viney R, Aaronson NK, Brazier JE, Cella D, Costa DSJ, Fayers PM, Kemmler G, Peacock S, Pickard AS , Rowen D et al (2016) . Quality of Life Research, 25(9), 2401-2401.
• Ferreira LN, Ferreira PL, Pereira LN & Rowen D (2016) . Applied Research in Quality of Life, 11(1), 329-329.
• Rowen D, Carlton J, Brazier JE, Mulhern B, Palfreyman S, Stevens K & Tsuchiya A (2010) . BMJ (Online), 341(7776), 746.

Preprints

• Wickramasekera N, Shackley P & Rowen D (2024) , JMIR Publications Inc..
• Acaster S, Mukuria C, Rowen D, Brazier JE, Wainwright CE, Quon BS, Duckers J, Quittner AL, Lou Y, Sosnay P & McGarry LJ () , Research Square Platform LLC.